Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
-
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
-
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Nuvation Bio to Present at the Jefferies London Healthcare Conference
-
Eloxx Pharmaceuticals Announces Key Corporate Accomplishments
-
ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
-
AI Solutions Startup Secures $15m in Fundraising Round
-
QIAGEN collaborates with McGill University to advance microbiome research
-
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Build-A-Bear Workshop, Inc. Declares Quarterly Cash Dividend
-
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
OrthoPediatrics Corp. to Participate in Upcoming Conferences
-
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
-
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Westrock Coffee Company to Participate in the Stephens Annual Investment Conference
-
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference
-
DoorDash CFO to Participate in Fireside Chat at Upcoming Investor Conference
-
KBRA Assigns Ratings to Various Sales Tax Securitization Corporation Sales Tax Securitization Bonds (AAA) and Second Lien Sales Tax Securitization Bonds (AA+); Affirms Ratings for Outstanding Bonds an
-
Eaton selected by the United States Air Force Research Laboratory to design innovative aerial refueling system
-
Amdocs Limited Reports Fourth Quarter & Fiscal Year 2024 Results
-
Paul Mueller Company Declares Quarterly Cash Dividend
-
Viant Technology Announces Acquisition of IRIS.TV
-
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
-
Progyny, Inc. Announces Third Quarter 2024 Results
-
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Monroe Capital Corporation BDC Announces Third Quarter 2024 Results
-
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
-
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
-
ElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech Award
-
American Public Education Reports Third Quarter 2024 Financial Results
-
V2X, INC. ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK
-
Voyager Reports Third Quarter 2024 Financial and Operating Results
-
Erasca Reports Third Quarter 2024 Business Updates and Financial Results
-
Perdoceo Education Corporation Reports Third Quarter and Year to Date 2024 Results
-
Direct Digital Holdings Reports Q3 2024 Financial Results
-
Skyworks Reports Q4 and Full Year FY24 Results
-
Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions
-
DAWSON GEOPHYSICAL REPORTS THIRD QUARTER 2024 RESULTS
-
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
-
Magnolia Oil & Gas Operating LLC Announces Pricing of Offering of $400 Million Senior Notes
-
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
-
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
-
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
-
Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
-
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

